Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction
Camilla Hage, Erik Michaëlsson, Cecilia Linde, et al.
Circulation Cardiovascular Genetics (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 20, pp. 2360-2372
Closed Access | Times Cited: 477
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288
Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes
Abbi D. Lane‐Cordova, Sadiya S. Khan, William A. Grobman, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 16, pp. 2106-2116
Closed Access | Times Cited: 193
Proteomic Evaluation of the Comorbidity-Inflammation Paradigm in Heart Failure With Preserved Ejection Fraction
Sandra Sanders‐van Wijk, Jasper Tromp, Lauren Beussink‐Nelson, et al.
Circulation (2020) Vol. 142, Iss. 21, pp. 2029-2044
Open Access | Times Cited: 160
Coronary microvascular dysfunction in hypertrophy and heart failure
Paolo G. Camici, Carsten Tschöpe, Marcelo F. Di Carli, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 4, pp. 806-816
Open Access | Times Cited: 143
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
Keenan A. Walker, Jingsha Chen, Jingning Zhang, et al.
Nature Aging (2021) Vol. 1, Iss. 5, pp. 473-489
Open Access | Times Cited: 138
Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life
Keenan A. Walker, Jingsha Chen, Shi Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Open Access | Times Cited: 72
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development
Amil M. Shah, Peder L. Myhre, Victoria Arthur, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Chemokines as Therapeutic Targets in Cardiovascular Disease
Heidi Noels, Christian Weber, Rory R. Koenen
Arteriosclerosis Thrombosis and Vascular Biology (2019) Vol. 39, Iss. 4, pp. 583-592
Open Access | Times Cited: 124
Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
Laurel A. Grisanti
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 122
Biomarkers in heart failure: the past, current and future
Sarhene Michael, Yili Wang, Jing Wei, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 6, pp. 867-903
Closed Access | Times Cited: 110
Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning
Åsa K. Hedman, Camilla Hage, Anil Kumar Sharma, et al.
Heart (2020) Vol. 106, Iss. 5, pp. 342-349
Open Access | Times Cited: 107
Do sodium‐glucose co‐transporter‐2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
Milton Packer
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 6, pp. 1361-1366
Closed Access | Times Cited: 94
Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome
Shihua Zhao, Cong Wang, Xue Hong, et al.
Kidney International (2019) Vol. 95, Iss. 4, pp. 815-829
Open Access | Times Cited: 90
Machine Learning-Derived Echocardiographic Phenotypes Predict Heart Failure Incidence in Asymptomatic Individuals
Masatake Kobayashi, Olivier Huttin, Martin Magnusson, et al.
JACC. Cardiovascular imaging (2021) Vol. 15, Iss. 2, pp. 193-208
Open Access | Times Cited: 63
Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure
Weiju Sun, Debing Du, Tongze Fu, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 60
Animal Models to Study Cardiac Arrhythmias
Daniel J. Blackwell, Jeffrey Schmeckpeper, Björn C. Knollmann
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1926-1964
Open Access | Times Cited: 44
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With Clinical Outcomes in HFpEF
Erik Michaëlsson, Lars H. Lund, Camilla Hage, et al.
JACC Heart Failure (2023) Vol. 11, Iss. 7, pp. 775-787
Open Access | Times Cited: 30
Determinants of COVID-19 vaccine-induced myocarditis
Jessica Rose, Nicolas Hulscher, Peter A. McCullough
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 12
Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study
Wenqin Guo, Lingyue Zhao, Weichao Huang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Metabolomic Profile in HFpEF vs HFrEF Patients
Camilla Hage, Lars Löfgren, Filippos Michopoulos, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 12, pp. 1050-1059
Closed Access | Times Cited: 69
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum
Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, et al.
International Journal of Cardiology (2019) Vol. 298, pp. 59-65
Closed Access | Times Cited: 60
Do most patients with obesity or type 2 diabetes, and atrial fibrillation, also have undiagnosed heart failure? A critical conceptual framework for understanding mechanisms and improving diagnosis and treatment
Milton Packer
European Journal of Heart Failure (2019) Vol. 22, Iss. 2, pp. 214-227
Open Access | Times Cited: 56
Omics phenotyping in heart failure: the next frontier
Antoni Bayés‐Genís, Peter P. Liu, David E. Lanfear, et al.
European Heart Journal (2020) Vol. 41, Iss. 36, pp. 3477-3484
Closed Access | Times Cited: 56
Towards precision medicine in heart failure
Chad S. Weldy, Euan A. Ashley
Nature Reviews Cardiology (2021) Vol. 18, Iss. 11, pp. 745-762
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top